Navigation Links
Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees
Date:10/6/2008

BOSTON, Oct. 6 /PRNewswire-USNewswire/ -- "A return to the use of chimpanzees in AIDS research and vaccine development is without scientific justification," according to a paper released today in the journal Alternatives to Laboratory Animals (ATLA). "An Assessment of the Role of Chimpanzees in AIDS Vaccine Research" concludes that vaccine responses in chimpanzees are not predictive of responses in humans, and that claims of chimpanzees' critical role and importance in AIDS vaccine development are without foundation.

The publication comes on the heels of recent vaccine failures in late-stage clinical trials, including one vaccine that appeared to increase vulnerability to HIV infection in human clinical trial participants, though the vaccine had proven safe and effective in tests in nonhuman primates. Yet some scientists are calling for a return to the use of chimpanzees, despite their previous failings.

Other scientists doubt that a return to their use would lead to likely success. According to the paper's author, geneticist Jarrod Bailey, Ph.D., Science Director for Project R&R: Release and Restitution for Chimpanzees in U.S. Laboratories: "At a cost of billions of dollars, most of the 85 AIDS vaccines created to date have been tested in hundreds of chimpanzees who endured decades of experiments and laboratory confinement. Almost all of these vaccines protected chimpanzees from HIV infection, but none has worked in humans. Claims of the continued importance of chimpanzee use are therefore misleading. For the millions of people at risk of AIDS, as well as the chimpanzees, we must move toward more humane and scientifically superior methods."

Chimpanzees have proven to be a failed and dangerous model for humans in not only AIDS research but in areas such as heart and cancer research as well.

In a May 2008 essay in Nature, NIAID Director and AIDS expert Dr. Anthony Fauci, when reflecting on the era of HIV/AIDS, noted: "We must learn from our missteps, build on our successes in treatment and prevention, and renew our commitment to developing the truly transforming tools that will one day put this scourge behind us."

According to Dr. Bailey, "The search for such a critically needed 'transforming tool' cannot include a return to using chimpanzees, one of the greatest 'missteps' in the history of AIDS research."

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Theodora, Capaldo, EdD

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=52615


'/>"/>
SOURCE NEAVS - Project R&R
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):